Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

BACKGROUND: Neuroimaging measures and chemical biomarkers may be important indices of clinical progression in normal aging and mild cognitive impairment (MCI) and need to be evaluated longitudinally. OBJECTIVE: To characterize cross-sectionally and longitudinally clinical measures in normal controls...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Petersen, R C., Aisen, P S., Beckett, L A., Donohue, M C., Gamst, A C., Harvey, D J., Jack, C R., Jagust, W J., Shaw, L M., Toga, A W., Trojanowski, J Q., Weiner, M W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Academy of Neurology 2010
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809036/
https://ncbi.nlm.nih.gov/pubmed/20042704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181cb3e25
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller